天祥药业品牌怎么样 申请店铺

我要投票 天祥药业在兽药行业中的票数:377 更新时间:2025-07-30
天祥药业是哪个国家的品牌?「天祥药业」是 新乡天祥药业有限公司 旗下著名品牌。该品牌发源于河南省新乡市,由创始人秦向林在2005-01-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力天祥药业品牌出海!将品牌入驻外推网,定制天祥药业品牌推广信息,可以显著提高天祥药业产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

天祥药业怎么样

新乡天祥药业有限公司是由新乡市兽药研究所与美国Cronell University药学院共同投资1500万建立的集兽药研发、生产、销售、动物保健、科技服务为一体的企业。公司坐落于美丽的新乡市亢村工业园区,占地面积48000平方米,建筑面积22000平方米。公司在引进外资的同时,引进了设备与技术,现有“粉剂/散剂/预混剂、水针剂(含中药提取)、大容量注射液(含中药提取)、口服液(含中药提取)、消毒剂、颗粒剂(含中药提取)”八个剂型车间;饲料线有:饲料添加剂(粉剂、液态)和预混合饲料两条生产线,车间布局合理、设备优良、科技含量高,设计年产量值2亿元。

新乡天祥药业有限公司现有员工200余人,其高级兽医师、教授、副教授10人,中级技术人员68人,大专以上学历占88.6%。公司在技术上依托于美国加州国立大学、美国康奈大学兽医学院、德国国家科学院、中国农大、河南科技学院、郑州牧专各院校。公司注重科技研发。由新乡市兽药研究所挂帅,依托新乡市兽药制剂工程技术研究中心,由专业知识渊博和实践经验丰富的药理学、病理学、药剂学的专家们组成一支实力强大的科研队伍,本着“以产品质量为农户服务,以科学技术为兽医创名”的产品理念。

新乡天祥药业有限公司引进了美国的企业管理理念,拥有一支经验丰富、技术精湛的技术服务团队和高学历、高素质、年轻化的营销团队,现具有完善的营销管理体系,公司现有兽药事业部、禽药事业部、生物科技事业部、天祥兽医院四个销售团队,以优质的产品、新的管理、专业的团队、技术精湛的售后服务团队,使我部的产品畅销在全国各地。

天祥人本着“待人以诚信、人不欺我”“待事以诚信、事无不成”的原则,愿与社会各界朋友携手共进,全心全意专注于动物保健事业的发展。


Xinxiang Tianxiang Pharmaceutical Co., Ltd. is an enterprise invested by Xinxiang Institute of veterinary medicine and cronell University College of pharmacy in the United States with a total investment of 15 million yuan, integrating the R & D, production, sales, animal health care and scientific and technological services of veterinary medicine. The company is located in the beautiful industrial park of Kangcun, Xinxiang City, covering an area of 48000 square meters and a building area of 22000 square meters. At the same time of introducing foreign investment, the company has introduced equipment and technology, and now there are eight dosage forms workshops of "powder / powder / premix, water injection (including Chinese medicine extraction), large volume injection (including Chinese medicine extraction), oral liquid (including Chinese medicine extraction), disinfectant, granule (including Chinese medicine extraction)"; the feed line includes: feed additive (powder, liquid) and premixed feed Production line, reasonable workshop layout, excellent equipment, high technology content, design annual output value of 200 million yuan. Xinxiang Tianxiang Pharmaceutical Co., Ltd. has more than 200 employees, including 10 senior veterinary doctors, professors and associate professors, 68 middle-level technicians, accounting for 88.6% of the total. The company relies on the National University of California, the school of veterinary medicine, the National Academy of Sciences, China Agricultural University, Henan University of science and technology, Zhengzhou pastoral college. The company pays attention to scientific research and development. Under the leadership of Xinxiang Veterinary Medicine Research Institute, relying on Xinxiang veterinary medicine engineering technology research center, a powerful scientific research team is composed of experts with profound professional knowledge and rich practical experience in pharmacology, pathology and pharmaceutics. It is based on the product concept of "serving farmers with product quality and creating famous veterinarians with science and technology". Xinxiang Tianxiang Pharmaceutical Co., Ltd. has introduced the enterprise management concept of the United States. It has an experienced and skilled technical service team and a highly educated, high-quality and young marketing team. Now it has a perfect marketing management system. The company has four sales teams, namely veterinary medicine business department, avian medicine business department, biotechnology business department and Tianxiang veterinary hospital, with high-quality products The new management, professional team and skilled after-sales service team make our products sell well all over the country. Based on the principle of "treating people with integrity, people don't deceive me" and "treating things with integrity, everything can be done", Tianxiang people are willing to work together with friends from all walks of life to focus on the development of animal health care.

本文链接: https://brand.waitui.com/472991d3b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

理想汽车-W获南向资金净买入20.93亿港元

南向资金今日净买入117.14亿港元。其中理想汽车-W、石药集团、美团-W净买入额位列前三,分别获净买入20.93亿港元、8.73亿港元、4.47亿港元。净卖出方面,中芯国际、信达生物、国泰君安国际分别遭净卖出2.05亿港元、1.21亿港元、0.74亿港元。(第一财经)

2小时前

“致知博约”完成数千万元Pre-A轮融资

36氪获悉,半导体封装材料企业“致知博约”近日完成数千万元Pre-A轮融资,由险峰长青、鼎兴量子、国汽投资、成都倍特及海河清韦五家机构联合注资。本轮资金将用于华南、长三角及四川三地生产基地建设,同步扩充研发团队并引入半导体封装检测设备。

2小时前

美丽生态:二季度新签订单金额合计3.48亿元

36氪获悉,美丽生态发布公告,公司2025年第二季度新签订单14个,金额合计3.48亿元。

2小时前

金河生物:上半年净利润1.38亿元,同比增51.52%

36氪获悉,金河生物披露半年度报告,公司2025年上半年实现营业收入为13.9亿元,同比增长30.45%;归属于上市公司股东的净利润1.38亿元,同比增长51.52%;基本每股收益0.18元。

2小时前

印度据悉仍致力于秋季之前与美国达成双边贸易协议

知情人士称,尽管美国总统唐纳德·特朗普推进威胁实施的关税,印度官员仍计划继续在今年秋季之前与美方磋商双边贸易协议。内部计算显示,如果对印度征收超过25%的关税,7月至9月期间约有10%的出口将受到影响。该知情人士表示,电子产品、宝石和珠宝等行业都将受到影响。(财联社)

2小时前

本页详细列出关于天祥药业的品牌信息,含品牌所属公司介绍,天祥药业所处行业的品牌地位及优势。
咨询